相关实验视频

Updated: May 27, 2025

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

患有弗里德里希的无氧症患者的多发性硬化症 (P4-6.016)

Yang Yu¹, Hani Kushlaf¹

¹Neurology, University of Cincinnati.

|February 20, 2025

概括

这份病例报告详细介绍了一名患有弗里德里希心症 (FRDA) 的患者,他被诊断患有多发性硬化症 (MS). 这项研究强调了在症状偏离典型的FRDA表现时考虑其他神经学诊断的重要性.

科学领域:

神经学神经学
遗传学是一个遗传学.
神经免疫学神经免疫学

背景情况:

弗里德里希病 (Friedreich's Ataxia,简称FRDA) 是一种罕见的遗传性神经退行性疾病,由Frataxin基因中的GAA三核酸重复扩张引起.
虽然FRDA中可能出现白质异常,但它们通常与多发性硬化症 (MS) 的诊断标准不一致.

研究的目的:

描述一个患有遗传确认FRDA的患者的临床表现和诊断过程,最终被诊断为MS.
强调在FRDA患者的临床特征与预期的疾病进程不一致时,需要考虑替代诊断.

主要方法:

一份病例报告详细介绍了一名22岁的女性,在10岁时被诊断出FRDA.
进行了临床检查,FRDA遗传检测,大脑和脊柱的MRI,CSF分析和广泛的血清检测.
用高剂量的静脉注射类固醇进行治疗,并进行随访MRI.

主要成果:

这名被诊断为FRDA的患者出现了新的神经症状,包括麻醉,虚弱和感觉丧失.
核磁共振扫描显示了多焦点白质病变,有些病变有增强,脑脊液显示了橄克隆带.
患者在使用类固醇时出现了改善,并在随访MRI上发现了新的增强性病变.

结论:

在FRDA患者中诊断MS是不常见的,需要对临床发现和诊断测试进行仔细的相关性.
对FRDA不典型的症状的出现需要对其他神经疾病进行全面评估,例如MS.

更多相关视频

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

相关概念视频

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...